Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03805841
Title Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene Fusions (RAIN)
Acronym RAIN
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Rain Therapeutics Inc.
Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.